Cargando…
Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis
Leishmaniasis is a neglected tropical disease, affecting more than 350 million people globally. However, there is currently no vaccine available against human leishmaniasis, and current treatment is hampered by high cost, side-effects, and painful administration routes. It has become a United Nation...
Autores principales: | Lourenço, Estela Mariana Guimarães, Di Iório, Juliana Fortes, da Silva, Fernanda, Fialho, Felipe Leonardo Bley, Monteiro, Melquisedeque Mateus, Beatriz, Adilson, Perdomo, Renata Trentin, Barbosa, Euzébio Guimarães, Oses, Jean Pierre, de Arruda, Carla Cardozo Pinto, de Souza Júdice, Wagner Alves, Rafique, Jamal, de Lima, Dênis Pires |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866541/ https://www.ncbi.nlm.nih.gov/pubmed/36677517 http://dx.doi.org/10.3390/microorganisms11010225 |
Ejemplares similares
-
Advances in Development of New Treatment for Leishmaniasis
por: de Menezes, Juliana Perrone Bezerra, et al.
Publicado: (2015) -
Spatio-temporal modeling of visceral leishmaniasis in Midwest Brazil: An ecological study of 18-years data (2001–2018)
por: Falcão de Oliveira, Everton, et al.
Publicado: (2020) -
In vitro ANTIGIARDIAL ACTIVITY OF THE CYSTEINE PROTEASE INHIBITOR
E-64
por: de Carvalho, Thaís Batista, et al.
Publicado: (2014) -
Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in an endemic area in the north of Minas Gerais, Brazil
por: de Carvalho, Fernando Henrique Guimarães, et al.
Publicado: (2020) -
Comparative analysis of the tissue inflammatory response in
human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)